- Home
- EBMT vs OPTN Comparison
EBMT vs OPTN Comparison
Compare EBMT & OPTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EBMT
- OPTN
- Stock Information
- Founded
- EBMT 1922
- OPTN 2010
- Country
- EBMT United States
- OPTN United States
- Employees
- EBMT N/A
- OPTN 132
- Industry
- EBMT Major Banks
- OPTN Biotechnology: Pharmaceutical Preparations
- Sector
- EBMT Finance
- OPTN Health Care
- Exchange
- EBMT Nasdaq
- OPTN Nasdaq
- Market Cap
- EBMT 120.7M
- OPTN 99.7M
- IPO Year
- EBMT N/A
- OPTN 2017
- Fundamental
- Price
- EBMT $16.34
- OPTN $0.67
- Analyst Decision
- EBMT
- OPTN Strong Buy
- Analyst Count
- EBMT 0
- OPTN 2
- Target Price
- EBMT N/A
- OPTN $4.00
- AVG Volume (30 Days)
- EBMT 11.0K
- OPTN 477.7K
- Earning Date
- EBMT 10-22-2024
- OPTN 11-07-2024
- Dividend Yield
- EBMT 3.53%
- OPTN N/A
- EPS Growth
- EBMT N/A
- OPTN N/A
- EPS
- EBMT 1.08
- OPTN N/A
- Revenue
- EBMT $80,564,000.00
- OPTN $75,058,000.00
- Revenue This Year
- EBMT N/A
- OPTN $24.44
- Revenue Next Year
- EBMT $7.72
- OPTN $49.00
- P/E Ratio
- EBMT $14.68
- OPTN N/A
- Revenue Growth
- EBMT N/A
- OPTN 3.91
- 52 Week Low
- EBMT $11.26
- OPTN $0.65
- 52 Week High
- EBMT $17.65
- OPTN $2.10
- Technical
- Relative Strength Index (RSI)
- EBMT 78.42
- OPTN 32.09
- Support Level
- EBMT $15.48
- OPTN $0.65
- Resistance Level
- EBMT $15.85
- OPTN $0.74
- Average True Range (ATR)
- EBMT 0.27
- OPTN 0.04
- MACD
- EBMT -0.01
- OPTN 0.00
- Stochastic Oscillator
- EBMT 88.25
- OPTN 20.00
About EBMT Eagle Bancorp Montana Inc.
Eagle Bancorp Montana Inc operates as a bank holding company. It provides loan and deposit services. The company focuses on residential loans, commercial real estate loans, commercial loans, consumer loans, and home equity loan products. The bank also offers deposit accounts which include checking, savings, money market, individual retirement accounts, and certificates of deposit accounts. It is a diversified lender with a focus on residential mortgage loans, commercial real estate mortgage loans, commercial business loans, agricultural loans, and second mortgage/home equity loan products.
About OPTN OptiNose Inc.
OptiNose Inc is a specialty pharmaceutical company that focuses on the development and commercialization of products for patients treated by ear, nose, and throat, and allergy specialists. Its product includes XHANCE (fluticasone propionate) nasal spray, 93 micrograms, a therapeutic utilizing its proprietary Exhalation Delivery System (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps. The XHANCE is able to deliver medication to the primary site of inflammation high and deep in the nasal passages in regions not adequately reached by intranasal steroids.